The DOI matches its Crossref record.
Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies.
Abstract
In vivo microdialysis was used to assess the involvement of ventral tegmental area (VTA) mu, delta, and kappa opioid receptors in modulation of basal extracellular ventral striatal dopamine (DA) and DA-metabolite concentrations. Independent groups of chloral hydrate-anesthetized rats were given VTA microinjections of selective opioid agonists, and extracellular ventral striatal DA and DA-metabolite concentrations were assayed using HPLC. VTA microinjections of [D-Ala2, N-Me-Phe4-Gly5-ol]-enkephalin (DAMGO; a mu agonist) and [D-Pen2, D-Pen5]-enkephalin (DDDPE; a delta agonist) each caused dose-orderly increases in ventral striatal DA and DA-metabolite concentrations. The effective concentrations of DPDPE were 100- to 1000-fold higher than the effective concentrations of DAMGO. VTA microinjections of (trans-(dl)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclo-hexyl]- benzeneacetamide) methane sulfonate hydrate (U-50,488H); a kappa agonist) failed to alter ventral striatal DA concentrations at any dose tested, but subsequent systemic injections significantly decreased DA and DA-metabolite concentrations. Pretreatment with VTA microinjections of 17-cyclopropylmethyl-6,7-dehydro-4,5-epoxy-3,14-dihydroxy-6,7,2',3'- indolmorphinan hydrochloride (naltrindole; a delta antagonist) (delta antagonist) antagonized VTA DPDPE-mediated increases in ventral striatal DA and DA-metabolite concentrations but failed to antagonize VTA DAMGO-mediated increases. Pretreatment with D-Pen-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP; a mu antagonist) antagonized VTA DAMGO-mediated increases but failed to antagonize VTA DPDPE-mediated increases. Thus both mu and delta receptor agonist appear capable of increasing ventral striatal DA and DA-metabolite concentrations through selective actions on their preferred class of opioid receptors in the VTA. The increases in ventral striatal DA and DA-metabolite concentrations that are seen after systemic treatment with kappa opioid agonists appear not to involve VTA opioid receptors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In particular, dynorphins decrease and enkephalins increase the release of DA (Devine et al. 1993; Di Chiara & Imperato 1988; Longoni et al. 1991; Pentney & Gratton 1991; Spanagel et al. 1990a,b, 1992).”
From Reward, addiction, withdrawal to nicotine (2011) · cites this paper as Devine et al. 1993
In the citing paper
“may reflect known interactions between the dopamine and endorphin systems in both humans and rodents (40, 55, 56), whereby endorphin activation may itself trigger a dopamine response”
From Variation in the β-endorphin, oxytocin, and dopamine receptor genes is associated with different dimensions of human sociality (2017) · cites this paper as [56]
Citations
Cites
Still being checked.
Cited by
Sorted by citations
Vanderschuren, L. J. M. J., & Kalivas, P. W. (2000) · Psychopharmacology · doi:10.1007/s002130000493 · Cited by 1,360
Wise, R. A. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80079-1 · Cited by 1,072
Self-citationMotivation, emotion, and their inhibitory control mirrored in brain oscillations
Knyazev, G. G. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.10.004 · Cited by 1,034
Wise, R. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00965-0 · Cited by 881
Self-citationAddictive Drugs and Brain Stimulation Reward
Wise, R. A. (1996) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.19.030196.001535 · Cited by 792
Self-citationEEG delta oscillations as a correlate of basic homeostatic and motivational processes
Knyazev, G. G. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.10.002 · Cited by 776
Drug-activation of brain reward pathways
Wise, R. A. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00063-5 · Cited by 684
Self-citationVentral Tegmental Area Neurons in Learned Appetitive Behavior and Positive Reinforcement
Fields, H. L., Hjelmstad, G. O., Margolis, E. B., & Nicola, S. M. (2007) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094341 · Cited by 632
Placebo effects on human μ-opioid activity during pain
Wager, T. D., Scott, D. J., & Zubieta, J.-K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702413104 · Cited by 562
The neurobiology of social play behavior in rats
Vanderschuren, L. J. M. J., Niesink, R. J. M., & Van Pee, J. M. (1997) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(96)00020-6 · Cited by 559
The Molecular and Behavioral Pharmacology of the Orphanin FQ/Nociceptin Peptide and Receptor Family
Mogil, J. S., & Pasternak, G. W. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01502-3 · Cited by 442
Role of brain dopamine in food reward and reinforcement
Wise, R. A. (2006) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2006.1854 · Cited by 436
Self-citationSpruijt, B. M., van den Bos, R., & Pijlman, F. T. A. (2001) · Applied Animal Behaviour Science · doi:10.1016/s0168-1591(00)00204-5 · Cited by 436
Fields, H. L., & Margolis, E. B. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.01.002 · Cited by 432
Goodman, A. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.030 · Cited by 445
Carlezon, W. A., Béguin, C., DiNieri, J. A., Baumann, M. H., Richards, M. R., Todtenkopf, M. S., Rothman, R. B., Ma, Z., Lee, D. Y.-W., & Cohen, B. M. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.092304 · Cited by 390
Dunbar, R. (2017) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2017.10.004 · Cited by 419
Reward, addiction, withdrawal to nicotine
De Biasi, M., & Dani, J. A. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113734 · Cited by 366
“In particular, dynorphins decrease and enkephalins increase the release of DA (Devine et al. 1993; Di Chiara & Imperato 1988; Longoni et al. 1991; Pentney & Gratton 1991; Spanagel et al. 1990a,b, 1992).”
BackgroundOpiate-like effects of sugar on gene expression in reward areas of the rat brain
Spangler, R., Wittkowski, K. M., Goddard, N. L., Avena, N. M., Hoebel, B. G., & LEIBOWITZ, S. F. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.02.013 · Cited by 255
Kappa opioid inhibition of morphine and cocaine self-administration in rats
Glick, S. D., Maisonneuve, I. M., Raucci, J., & Sydney, A. (1995) · Brain Research · doi:10.1016/0006-8993(95)00306-b · Cited by 245
The endogenous opioid system: A common substrate in drug addiction
Trigo, J. M., Martín‐García, E., Berrendero, F., Robledo, P., & Maldonado, R. J. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.10.011 · Cited by 250
Dopamine receptors—physiological understanding to therapeutic intervention potential
Emilien, G. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00029-7 · Cited by 232
Shaham, Y., Rajabi, H., & Stewart, J. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-05-01957.1996 · Cited by 214
Intracranial Self-Stimulation to Evaluate Abuse Potential of Drugs
Negus, S. S., & Miller, L. L. (2014) · Pharmacological Reviews · doi:10.1124/pr.112.007419 · Cited by 216
Ciccocioppo, R. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00302-0 · Cited by 203
Identification of Rat Ventral Tegmental Area GABAergic Neurons
Margolis, E. B., Toy, B. C., Himmels, P., Morales, M., & Fields, H. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042365 · Cited by 215
Fadda, P., Scherma, M., Fresu, A., Collu, M., & Fratta, W. (2003) · Synapse · doi:10.1002/syn.10238 · Cited by 200
Zhang, Y., Butelman, E. R., Schlussman, S. D., Ho, A., & Kreek, M. J. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2087-0 · Cited by 196
Wise, R. A., Leone, P., Rivest, R., & Leeb, K. (1995) · Synapse · doi:10.1002/syn.890210207 · Cited by 190
Self-citationEndogenous opioids: overview and current issues
Akil, H., Owens, C. E., Gutstein, H. B., Taylor, L. P., Curran, E. J., & Watson, S. J. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00071-4 · Cited by 180
Sexual Behavior and Sex-Associated Environmental Cues Activate the Mesolimbic System in Male Rats
Balfour, M. E., Yu, L., & Coolen, L. M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300350 · Cited by 177
Volman, S. F., Lammel, S., Margolis, E. B., Kim, Y., Richard, J. M., Roitman, M. F., & Lobo, M. K. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.3250-13.2013 · Cited by 168
Endogenous opioids and feeding behavior: a 30-year historical perspective
Bodnar, R. J. (2004) · Peptides · doi:10.1016/j.peptides.2004.01.006 · Cited by 170
Elman, I., Borsook, D., & Lukas, S. E. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301051 · Cited by 169
Effects of Kappa Opioids on Cocaine Self-Administration by Rhesus Monkeys
Negus, S. S., Mello, N. K., Portoghese, P. S., & Lin, C. E. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36769-2 · Cited by 169
Orphanin FQ/Nociceptin Modulation of Mesolimbic Dopamine Transmission Determined by Microdialysis
Murphy, N. P., & Maidment, N. T. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730179.x · Cited by 167
The dynorphin/κ-opioid receptor system and its role in psychiatric disorders
Tejeda, H. A., Shippenberg, T. S., & Henriksson, R. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0844-x · Cited by 161
Kappa-opioid ligands in the study and treatment of mood disorders
Carlezon, W. A., Béguin, C., Knoll, A. T., & Cohen, B. M. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.05.008 · Cited by 156
Nicotine self-administration in animals as a dependence model
Corrigall, W. A. (1999) · Nicotine & Tobacco Research · doi:10.1080/14622299050011121 · Cited by 156
Corrigall, W., Coen, K. M., Adamson, K. L., Chow, B. L., & Zhang, J. (2000) · Psychopharmacology · doi:10.1007/s002139900355 · Cited by 152
Dopamine Reuptake Inhibition in the Rostral Agranular Insular Cortex Produces Antinociception
Burkey, A. R., Carstens, E. E., & Jasmin, L. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-10-04169.1999 · Cited by 151
Interactions between Kappa Opioid Agonists and Cocaine: Preclinical Studies
Mello, N. K., & Negus, S. S. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06678.x · Cited by 145
Lucas, L., Celen, Z., Tamashiro, K. L., Blanchard, R. J., Blanchard, D. C., Markham, C. M., Sakai, R. R., & McEwen, B. S. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.12.009 · Cited by 145
Effects of Kappa Opioid Agonists on Cocaine- and Food-Maintained Responding by Rhesus Monkeys
Mello, N. K., & Negus, S. S. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37657-8 · Cited by 141
Hyytiä, P., & Kiianmaa, K. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02123.x · Cited by 140
Motivation and Self-Regulation in Addiction: A Call for Convergence
Köpetz, C. E., Lejuez, C. W., Wiers, R. W., & Kruglanski, A. W. (2013) · Perspectives on Psychological Science · doi:10.1177/1745691612457575 · Cited by 138
Mapping of chemical trigger zones for reward
Ikemoto, S., & Wise, R. A. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.07.012 · Cited by 140
Self-citationSvingos, A. L., Chavkin, C., Colago, E. E. O., & Pickel, V. M. (2001) · Synapse · doi:10.1002/syn.10005 · Cited by 136
Tejeda, H. A., Counotte, D. S., Oh, E. J., Ramamoorthy, S., Schultz‐Kuszak, K., Bäckman, C. M., Chefer, V., O’Donnell, P., & Shippenberg, T. S. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.76 · Cited by 132
Presynaptic Opioid and Nicotinic Receptor Modulation of Dopamine Overflow in the Nucleus Accumbens
Britt, J. P., & McGehee, D. S. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.4275-07.2008 · Cited by 130
Pearce, E., Wlodarski, R., Machin, A., & Dunbar, R. I. M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700712114 · Cited by 131
Shippenberg, T. S., & Rea, W. P. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00450-9 · Cited by 130
Functional implications of glutamatergic projections to the ventral tegmental area
Geisler, S., & Wise, R. A. (2008) · Reviews in the Neurosciences · doi:10.1515/revneuro.2008.19.4-5.227 · Cited by 125
Self-citationBechtholt, A. J., & Cunningham, C. L. (2005) · Behavioral Neuroscience · doi:10.1037/0735-7044.119.1.213 · Cited by 124
GABAergic MECHANISMS OF OPIATE REINFORCEMENT
Xi, Z. (2002) · Alcohol and Alcoholism · doi:10.1093/alcalc/37.5.485 · Cited by 127
Marinelli, P. W., Quirion, R., & Gianoulakis, C. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1490-2 · Cited by 122
Kuzmin, A. V., Semenova, S., Gerrits, M. A. F. M., Zvartau, E. E., & van Ree, J. M. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00961-2 · Cited by 122
Bontempi, B., & Sharp, F. R. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-21-08596.1997 · Cited by 121
β-Endorphin and drug-induced reward and reinforcement
Roth‐Deri, I., Green-Sadan, T., & Yadid, G. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.06.003 · Cited by 126
The selective κ-opioid receptor agonist U50,488H attenuates voluntary ethanol intake in the rat
Lindholm, S., Werme, M., Brené, S., & Franck, J. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00368-5 · Cited by 116
Gray, A. M., Rawls, S. M., Shippenberg, T. S., & McGinty, J. F. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731066.x · Cited by 116
Hipólito, L., Wilson‐Poe, A. R., Campos‐Jurado, Y., Zhong, E., González-Romero, J. L., Virag, L., Whittington, R. A., Comer, S. D., Carlton, S. M., Walker, B. M., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.1053-15.2015 · Cited by 114
Young, K. A., Gobrogge, K. L., & Wang, Z. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.06.004 · Cited by 118
Brain Reward Circuits in Morphine Addiction
Kim, J., Ham, S., Hong, H., Moon, C., & Im, H. (2016) · Molecules and Cells · doi:10.14348/molcells.2016.0137 · Cited by 117
Tejeda, H. A., & Bonci, A. (2018) · Brain Research · doi:10.1016/j.brainres.2018.09.023 · Cited by 117
Xi, Z., Fuller, S. A., & Stein, E. A. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37186-1 · Cited by 107
Garzón, M., & Pickel, V. M. (2001) · Synapse · doi:10.1002/syn.1088 · Cited by 106
Ghrelin Interacts with Neuropeptide Y Y1 and Opioid Receptors to Increase Food Reward
Skibicka, K. P., Shirazi, R. H., Hansson, C., & Dickson, S. L. (2011) · Endocrinology · doi:10.1210/en.2011-1606 · Cited by 103
Regulation of the mesolimbic dopamine circuit by feeding peptides
Liu, S., & Borgland, S. L. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2014.12.046 · Cited by 104
Yoshida, Y., Koide, S., Hirose, N., Takada, K., Tomiyama, K., Koshikawa, N., & Cools, A. R. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00046-9 · Cited by 102
The opioid system in depression
Jelen, L. A., Stone, J. M., Young, A. H., & Mehta, M. A. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104800 · Cited by 108
Valdez, G. R., Platt, D. M., Rowlett, J. K., Rüedi-Bettschen, D., & Spealman, R. D. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.125484 · Cited by 99
Opioid propeptide mRNA content and receptor density in the brains of AA and ANA rats
Marinelli, P. W., Kiianmaa, K., & Gianoulakis, C. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00517-8 · Cited by 99
Modulation of drug-induced sensitization processes by endogenous opioid systems
Spanagel, R. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(94)00176-g · Cited by 99
The stimulatory effects of opioids and their possible role in the development of tolerance
Smart, D., & Lambert, D. G. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)10023-7 · Cited by 99
Dual Roles of Dopamine in Food and Drug Seeking: The Drive-Reward Paradox
Wise, R. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.09.001 · Cited by 100
Self-citationJentsch, J. D., Tran, A., Taylor, J. R., & Roth, R. H. (1998) · Psychopharmacology · doi:10.1007/s002130050649 · Cited by 97
Svingos, A. L., Clarke, C. L., & Pickel, V. M. (1999) · Synapse · doi:10.1002/(sici)1098-2396(199910)34:1 · Cited by 67
Roth‐Deri, I., Zangen, A., Aleli, M., Goelman, R. G., Pelled, G., Nakash, R., Gispan-Herman, I., Green, T., Shaham, Y., & Yadid, G. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01584.x · Cited by 94
Elmer, G. I., Pieper, J. O., Rubinstein, M., Low, M. J., Grandy, D. K., & Wise, R. A. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-10-j0004.2002 · Cited by 94
Self-citationGiannuario, A. D., & Pieretti, S. (2000) · Peptides · doi:10.1016/s0196-9781(00)00250-3 · Cited by 90
Morani, A. S., Kivell, B. M., Prisinzano, T. E., & Schenk, S. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.09.002 · Cited by 89
Margolis, E. B., Fields, H. L., Hjelmstad, G. O., & Mitchell, J. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.4569-08.2008 · Cited by 90
Nylander, I., Vlaskovska, M. V., & Terenius, L. Y. (1995) · Brain Research · doi:10.1016/0006-8993(95)00279-y · Cited by 87
Hirose, N., Murakawa, K., Takada, K., Oi, Y., Suzuki, T., Nagase, H., Cools, A. R., & Koshikawa, N. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.03.065 · Cited by 86
Negus, S. S. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1878-7 · Cited by 83
The role of the opioid system in alcohol dependence
Nutt, D. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113504017 · Cited by 87
Bergevin, A., Girardot, D., Bourque, M.-J., & Trudeau, L. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00061-8 · Cited by 83
Nicotine and endogenous opioids: neurochemical and pharmacological evidence
Hadjiconstantinou, M., & Neff, N. H. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.11.010 · Cited by 81
Kilpatrick, M., Rooney, M. B., MICHAEL, D., & Wightman, R. M. (2000) · Neuroscience · doi:10.1016/s0306-4522(99)00578-3 · Cited by 80
Kotlinska, J. H., Wichmann, J., Łęgowska, A., Rolka, K., & Silberring, J. (2002) · Behavioural Pharmacology · doi:10.1097/00008877-200205000-00006 · Cited by 78
Mu‐opioid receptor knockout mice show diminished food‐anticipatory activity
Kas, M. J., van den Bos, R., Baars, A. M., Lubbers, M. E., Lesscher, H. M. B., Hillebrand, J. J., Schuller, A. G., Pintar, J. E., & Spruijt, B. M. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03581.x · Cited by 77
Radioligand-binding study of noribogaine, a likely metabolite of ibogaine
Pearl, S. M., Herrick‐Davis, K., Teitler, M., & Glick, S. D. (1995) · Brain Research · doi:10.1016/0006-8993(95)00123-8 · Cited by 78
Salvinorin A: Allosteric Interactions at the μ-Opioid Receptor
Rothman, R. B., Murphy, D. L., Xu, H., Godin, J. A., Dersch, C. M., Partilla, J. S., Tidgewell, K. J., Schmidt, M. D., & Prisinzano, T. E. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.113167 · Cited by 76
Devine, D. P., Leone, P., & Wise, R. A. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90167-g · Cited by 75
Self-citationAberrant mesolimbic dopamine–opiate interaction in obesity
Tuominen, L. J., Tuulari, J. J., Karlsson, H., Hirvonen, J., Helin, S., Salminen, P. T. P., Parkkola, R. K., Hietala, J. A., Nuutila, P., & Nummenmaa, L. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2015.08.001 · Cited by 72
Gerrits, M. A. F. M., van Ree, J. M., Patkina, N. A., & Zvartau, E. E. (1995) · Psychopharmacology · doi:10.1007/bf02246059 · Cited by 73
Archer, S., Glick, S. D., & Bidlack, J. M. (1996) · Neurochemical Research · doi:10.1007/bf02532378 · Cited by 73
Wiskerke, J., Schetters, D., van Es, I. E., van Mourik, Y., den Hollander, B., Schoffelmeer, A. N. M., & Pattij, T. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4794-10.2011 · Cited by 68
David, V., Durkin, T., & Cazala, P. (2002) · Psychopharmacology · doi:10.1007/s00213-001-0981-2 · Cited by 71
Metadata
- Authors
- Devine, D. P., Leone, P., Pocock, D., & Wise, R. A.
- Affiliations
- Concordia University (CA)
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 1993-07
- Volume
- 266
- Issue
- 3
- Pages
- 1236-1246
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2108098398
- Cited by
- 382
- References
- 0
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 3 · 2023: 4 · 2022: 4 · 2021: 9 · 2020: 8 · 2019: 10 · 2018: 5 · 2017: 10 · 2016: 7 · 2015: 10 · 2014: 7 · 2013: 13 · 2012: 10
- FWCI
- 3.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pharmacology and Experimental Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- PubMed
- Funders
- National Institute on Drug Abuse (DA1720)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- ventral tegmental area, mu-opioid receptor, delta opioid receptor, kappa opioid receptor, dopamine release, ventral striatum, dopamine metabolites, DAMGO, DPDPE, U50,488H, naltrindole, CTOP, mesolimbic dopamine system, opioid receptor selectivity, enkephalin, opioid agonists, opioid antagonists
- MeSH terms
- Amino Acid Sequence, Analgesics, Animals, Chromatography, High Pressure Liquid, Corpus Striatum, Dialysis, Dopamine, Enkephalins, Homovanillic Acid, Hydroxyindoleacetic Acid, Limbic System, Male, Microinjections, Molecular Sequence Data, Naltrexone, Narcotic Antagonists, Pyrrolidines, Rats, Inbred Strains, Receptors, Opioid, Tegmentum Mesencephali, 3,4-Dihydroxyphenylacetic Acid, 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer, Enkephalin, Ala(2)-MePhe(4)-Gly(5)-, Enkephalin, D-Penicillamine (2,5)-, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review